BeStock  

Stryker Corp SYK

US equityMarket cap rank #160AI medical concept stocksRobotics
$325.87 −$9.21 (-2.75%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $326.00 +0.04%
Open$324.41
Prev close$335.08
Day range$322.56 – $328.02
Volume3.78M
Market cap$124.06B
P/E (TTM)34.7
Dividend yield1.08%

Earnings

Average move on report day±3.6%last 16 reports
Closed higher5 of 1631% of the time
Best reaction+9.9%
Worst reaction-6.5%

Stock move on the day after each report

-0.7%2023/Q3-2.5%2024/Q1-0.8%2024/Q2+1.2%2024/Q3-1.0%2024/Q4+1.1%2025/Q1-3.8%2025/Q2-3.5%2025/Q3+4.3%2025/Q4-6.5%2026/Q1-6.4%2026/Q2-6.4%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q329 Oct 2026After Market±7.1%-6.38%Within range
2026/Q230 Jul 2026After Market±6.5%-6.42%Within range
2026/Q130 Apr 2026After Market±5.5%-6.47%Bigger than priced
2025/Q429 Jan 2026After Market±5.1%+4.31%Within range
2025/Q330 Oct 2025After Market±5.0%-3.45%Within range
2025/Q231 Jul 2025After Market±5.5%-3.80%Within range
2025/Q11 May 2025After Market±6.7%+1.13%Within range
2024/Q428 Jan 2025After Market±6.0%-1.03%Within range
2024/Q329 Oct 2024After Market±6.7%+1.23%Within range
2024/Q230 Jul 2024After Market±7.0%-0.84%Within range
2024/Q130 Apr 2024After Market±5.4%-2.49%Within range
2023/Q32 Nov 2023After Market±5.8%-0.72%Within range
2023/Q23 Aug 2023After Market±5.5%+2.94%Within range
2023/Q11 May 2023After Market±5.9%-2.00%Within range
2022/Q431 Jan 2023After Market±6.1%+9.91%Bigger than priced
2022/Q331 Oct 2022After Market±5.3%-3.99%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • MedSurg and Neurotechnology$3.63B 55.0%
  • Orthopaedics$2.96B 45.0%

Latest reported quarter: Q2, ended Jun 2026

Revenue$6.59B+9.4% YoY
Operating profit$1.66B+42.1% YoY
Net profit$1.28B+44.3% YoY
Diluted EPS$3.30+44.1% YoY
Free cash flow$1.06B+14.1% YoY
Operating cash flow$1.26B

Revenue, last 8 quarters

$5.5BSep '24$6.4BDec '24$5.9BMar '25$6.0BJun '25$6.1BSep '25$7.2BDec '25$6.0BMar '26$6.6BJun '26

Net profit, last 8 quarters

$834.0MSep '24$546.0MDec '24$654.0MMar '25$884.0MJun '25$859.0MSep '25$849.0MDec '25$745.0MMar '26$1.3BJun '26

Profitability & balance sheet

Gross margin65.0%
Operating margin21.7%
Net margin14.4%
Return on equity16.5%
Return on assets7.9%
Return on invested capital10.9%
Current ratio2.16
Liabilities / assets50.4%
Cash & investments$3.27B
Total debt$14.93B
Net cash (debt)-$11.66B
Free cash flow / sales18.2%

Discussion

No comments yet — be the first to weigh in on SYK.

Sign in to join the discussion.

Scroll to Top